{"id":"sugammadex-injectable-product","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Tachycardia"}]},"_chembl":{"chemblId":"CHEMBL2111107","moleculeType":"Oligosaccharide","molecularWeight":"2002.18"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sugammadex works by forming a tight 1:1 complex with steroidal neuromuscular blocking drugs (such as rocuronium and vecuronium), effectively removing them from the neuromuscular junction and plasma. This encapsulation rapidly restores neuromuscular function without requiring acetylcholinesterase inhibitors. The drug is particularly useful for rapid reversal of deep neuromuscular blockade in anesthesia.","oneSentence":"Sugammadex is a selective relaxant binding agent that encapsulates and inactivates steroidal neuromuscular blocking agents, rapidly reversing neuromuscular blockade.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:58.388Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults undergoing surgery"},{"name":"Reversal of deep neuromuscular blockade in anesthetized patients"}]},"trialDetails":[{"nctId":"NCT06035757","phase":"PHASE4","title":"The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery","status":"RECRUITING","sponsor":"Konkuk University Medical Center","startDate":"2023-12-01","conditions":"Emergence Delirium, Strabismus, Pediatric ALL","enrollment":76},{"nctId":"NCT06112353","phase":"PHASE4","title":"Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2024-04-17","conditions":"Intestinal Disease","enrollment":128},{"nctId":"NCT06398899","phase":"NA","title":"Sugammadex v.s. Neostigmine/Glycopyrrolate","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2024-05-01","conditions":"Head and Neck Surgery, Chronic Sinusitis, Chronic Otitis Media","enrollment":124},{"nctId":"NCT05887375","phase":"PHASE4","title":"Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"University of Missouri-Columbia","startDate":"2023-08-03","conditions":"Spine Surgery, Reversal of Neuromuscular Blockade, Urinary Retention Postoperative","enrollment":118},{"nctId":"NCT07092046","phase":"NA","title":"Minimal Flow Anesthesia and Infection Risk","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-07-01","conditions":"Minimal Flow Anesthesia, General Anaesthesia, Inhalation Anesthesia","enrollment":140},{"nctId":"NCT05354466","phase":"PHASE4","title":"Perioperative Respiratory Adverse events_sugammadex","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2022-06-27","conditions":"Respiratory Complication","enrollment":174},{"nctId":"NCT03943888","phase":"PHASE2","title":"Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2019-08-12","conditions":"Anesthesia, General, Neuromuscular Blockade","enrollment":40},{"nctId":"NCT04347486","phase":"PHASE2","title":"Pharmacokinetic-pharmacodynamic Analysis of Sugammadex for Conventional Reversal in Children","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2020-04-29","conditions":"Anesthesia, General, Neuromuscular Blockade","enrollment":32},{"nctId":"NCT04407078","phase":"NA","title":"Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Female","status":"COMPLETED","sponsor":"Ajou University School of Medicine","startDate":"2019-12-02","conditions":"Gallbladder Diseases","enrollment":40},{"nctId":"NCT03689413","phase":"NA","title":"Adequate Dosage of Sugammadex on Thyroid Surgery","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2018-10-01","conditions":"Thyroid Surgery","enrollment":102},{"nctId":"NCT03583021","phase":"NA","title":"Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Male","status":"COMPLETED","sponsor":"Ajou University School of Medicine","startDate":"2018-06-25","conditions":"Gallbladder Diseases","enrollment":42},{"nctId":"NCT03619759","phase":"","title":"The Effect of Sugammadex on the Outcome After Colorectal Cancer Surgery","status":"COMPLETED","sponsor":"Ajou University School of Medicine","startDate":"2018-03-22","conditions":"Outcome, Fatal","enrollment":585},{"nctId":"NCT03144453","phase":"PHASE4","title":"Recovery From Anesthesia After Robotic Assisted Radical Cystectomy","status":"UNKNOWN","sponsor":"Regina Elena Cancer Institute","startDate":"2017-05-02","conditions":"Anesthesiology Management","enrollment":50},{"nctId":"NCT01728584","phase":"PHASE4","title":"A Study Comparing the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures in Participants Undergoing Laparoscopic Cholecystectomy (P07982)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-11-28","conditions":"Gallbladder Disease","enrollment":127},{"nctId":"NCT02666014","phase":"PHASE3","title":"Sugammadex Versus Neostigmine for Postoperative Nausea and Vomiting After Laparoscopic Gynaecological Surgery","status":"COMPLETED","sponsor":"KK Women's and Children's Hospital","startDate":"2015-06","conditions":"Postoperative Nausea and Vomiting","enrollment":184},{"nctId":"NCT02601508","phase":"NA","title":"Compare of Surgical Condition and Complications With Moderate and Deep NM Block","status":"UNKNOWN","sponsor":"Chonnam National University Hospital","startDate":"2015-11","conditions":"Neuromuscular Blockade","enrollment":80},{"nctId":"NCT02284412","phase":"PHASE4","title":"Functional Respiratory Imaging After Neostigmine or Sugammadex","status":"COMPLETED","sponsor":"Onze Lieve Vrouw Hospital","startDate":"2014-12","conditions":"Respiratory-Gated Imaging Techniques","enrollment":13}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Sugammadex Injectable Product","genericName":"Sugammadex Injectable Product","companyName":"Regina Elena Cancer Institute","companyId":"regina-elena-cancer-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sugammadex is a selective relaxant binding agent that encapsulates and inactivates steroidal neuromuscular blocking agents, rapidly reversing neuromuscular blockade. Used for Reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults undergoing surgery, Reversal of deep neuromuscular blockade in anesthetized patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}